Form 603 Corporations Act 2001 Section 671B Notice of initial substantial holder To Company/registered scheme/notified foreign passport fund name Chimeric Therapeutics Limited ACN/ARSN/APFRN 638 835 828 1. Details of substantial holder (1) Name Magellan Financial Group Ltd (MFG) and each...
Notice of initial substantial holder for CHM
Filed with ASX · · 6 pages · English
Release
Chimeric Therapeutics Limited on 6ix
Earlier from Chimeric Therapeutics
- Final Director's Interest Notice - LR
- Final Director's Interest Notice - BG
- Initial Director's Interest Notice - RM
- FY2026 Annual Report, creditor update and Board changes
- Application for quotation of securities - CHM
Later from Chimeric Therapeutics
- Ceasing to be a substantial holder for CHM
- Quarterly Activities/Appendix 4C Cash Flow Report
- Notice of Annual General Meeting/Proxy Form
- Notification of cessation of securities - CHM
Follow Chimeric Therapeutics into a list and get an email when it puts out news.
Follow Chimeric Therapeutics